PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71961-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)71961-1/fulltext
Title :
PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71961-1&doi=10.1016/S1098-3015(11)71961-1
First page :
A263
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
119